Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
Liliana OliverRydell AlvarezRaquel DiazAnet ValdésSean H ColliganMichael J NemethDanielle Y F TwumAudry FernándezOlivia Fernández-MedinaLouise M CarlsonHan YuKevin H EngMary L HensenMaura L Rábade-ChediakLuis Enrique FernándezKelvin P LeeLeslie PerezJason B MuhitchCirce MesaScott I AbramsPublished in: Journal for immunotherapy of cancer (2022)
Altogether, these data revealed VSSP as a novel regulator of myeloid biology that mitigates MDSCs in cancer patients and reinstates a more normal myeloid phenotype that potentially favors immune activation over immune suppression.